NovoLog PenFill and Rituxan Hycela
Determining the interaction of NovoLog PenFill and Rituxan Hycela and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: hyaluronidase / rituximab
Brand name: Rituxan Hycela
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog PenFill-Rituximab
- NovoLog PenFill-Rituximab and Hyaluronidase
- NovoLog PenFill-Rituximab and hyaluronidase human, recombinant Subcutaneous
- NovoLog PenFill-Rituximab Intravenous
- NovoLog PenFill-Riva-Amoxicillin
- NovoLog PenFill-Rivaroxaban
- Rituxan Hycela-Novoseven
- Rituxan Hycela-NovoSeven RT
- Rituxan Hycela-NovoSeven RT with MixPro injection
- Rituxan Hycela-Novothyrox
- Rituxan Hycela-Noxafil
- Rituxan Hycela-Noxafil (Posaconazole Delayed-Release Tablets)